Liver histology in rheumatoid arthritis patients receiving long‐term methotrexate therapy. A Prospective Study with Baseline and Sequential Biopsy Samples

Arthritis & Rheumatism

Volumn 32, Issue 2, 1989, Pages 121-127

  Kremer, Joel M ^a   Lee, Randall G ^b   Tolman, Keith G ^b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADULT; BIOPSY; CLINICAL ARTICLE; FEMALE; HISTOLOGY; HUMAN; LIVER; LIVER FIBROSIS; LIVER TOXICITY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ADMINISTRATION, ORAL; ADULT; AGED; ARTHRITIS, RHEUMATOID; ASPARTATE AMINOTRANSFERASES; BIOPSY; COMPARATIVE STUDY; FEMALE; HUMAN; LIVER; LIVER CIRRHOSIS; MALE; METHOTREXATE; MIDDLE AGE; PROSPECTIVE STUDIES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TIME FACTORS;

EID: 0024504349     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/anr.1780320202     Document Type: Article

References (36)

1. Efficacy of low‐dose methotrexate in rheumatoid arthritis
2. Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial
3. Weekly pulse methotrexate in rheumatoid arthritis: clinical and immunologic effects in a randomized, double‐blind study
4. The safety and efficacy of the use of methotrexate in long‐term therapy for rheumatoid arthritis
5. Low‐dose methotrexate treatment of rheumatoid arthritis: long‐term observations
6. Long term prospective study of methotrexate in rheumatoid arthritis
7. Methotrexate‐induced pneumonitis
8. Acute lung disease associated with low‐dose pulse methotrexate therapy in patients with rheumatoid arthritis
9. Pneumonitis complicating low‐dose methotrexate therapy in rheumatoid arthritis
10. Pulmonary disease during the treatment of rheumatoid arthritis with low‐dose pulse methotrexate
11. Liver biopsies from psoriatics related to methotrexate therapy: findings in post‐methotrexate liver biopsies from 160 psoriatics
12. Methotrexate‐induced liver cirrhosis: studies including serial liver biopsies during continued treatment
13. Methotrexate hepatotoxicity in psoriasis: consideration of liver biopsies at regular intervals
14. Methotrexate maintenance therapy and liver damage in psoriasis
15. The liver in rheumatoid arthritis
16. Studies on the frequency and pathologies of liver involvement in rheumatoid arthritis
17. Morphological changes in liver biopsies from patients with rheumatoid arthritis
18. Pretreatment liver histology in rheumatoid arthritis patients treated with low dose methotrexate (abstract)
19. Hepatic histology following prolonged treatment of rheumatoid arthritis with bolus methotrexate (abstract)
20. Liver biopsies in patients on low dose pulse methotrexate for the treatment of rheumatoid arthritis (abstract)
21. Liver biopsy findings in patients with rheumatoid arthritis and psoriatic arthritis on long‐term treatment with methotrexate (abstract)
22. Low incidence of hepatotoxicity associated with long‐term, low dose oral methotrexate in treatment of refractory psoriasis, psoriatic arthritis and rheumatoid arthritis
23. 1958 revision of diagnostic criteria for rheumatoid arthritis
24. Therapeutic criteria in rheumatoid arthritis
25. HLA antigens in methotrexate‐induced liver cirrhosis
26. Ibuprofen
27. Diclofenac hepatitis
28. Cholestatic jaundice caused by sulindac
29. Hepatotoxicity of methotrexate in the treatment of psoriasis
30. Psoriasis‐liver methotrexate interactions
31. Complications following percutaneous liver biopsy: a multicentre retrospective study on 68,276 biopsies
32. Das Risiko der perkatanen Leberbiopsie
33. Ueber Vorteil und Risiko der Leberbiopsie Methode nach Meughini
34. Macroscopic diagnosis in liver biopsy